SCHEMBL4807004

SCHEMBL4807004

CSc1ccc(-c2noc(C(F)(F)Br)c2-c2ccccc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.56
ESR2 Q92731 1/20 0.56
PTGS2 P35354 13/20 0.53
PTGS1 P23219 6/20 0.45
MLYCD O95822 2/20 0.42
GABRA5 P31644 1/20 0.39
MT-CO2 P00403 3/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
LMNA P02545 1/20 0.39
CA3 P07451 1/20 0.39
ADRB2 P07550 1/20 0.39
ADRB1 P08588 1/20 0.39
CYP3A4 P08684 1/20 0.39
ADORA3 P0DMS8 1/20 0.39
CHRM1 P11229 1/20 0.39
ADRA2B P18089 1/20 0.39
CA4 P22748 1/20 0.39
CA6 P23280 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14163954 0.90 ESR1 (0.68) ESR1ESR2PTGS2PTGS1MLYCD
SCHEMBL22827980 0.86 ESR1 (0.49) ESR1ESR2PTGS2PTGS1MLYCD
SCHEMBL22828297 0.84 ESR1 (0.50) ESR1ESR2PTGS2PTGS1MLYCD
SCHEMBL4806543 0.79 PTGS2 (0.83) ESR1ESR2PTGS2PTGS1MT-CO2
SCHEMBL6168295 0.79 PTGS2 (0.75) PTGS2PTGS1GABRA5MT-CO2CA12
SCHEMBL4029668 0.77 PTGS2 (0.50) ESR1ESR2PTGS2PTGS1MLYCD
SCHEMBL4028144 0.77 PTGS2 (0.50) ESR1ESR2PTGS2PTGS1GABRA5
SCHEMBL6169671 0.77 PTGS2 (0.46) ESR1ESR2PTGS2PTGS1MLYCD
SCHEMBL22827965 0.76 PTGS2 (0.56) ESR1ESR2PTGS2PTGS1GABRA5
SCHEMBL6439781 0.71 ESR1 (1.00) ESR1ESR2PTGS2PTGS1MLYCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020257653-A1 RADIOLABELED COMPOUNDS AND USES THEREOF THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2020-12-24 WO disclosed
US-7329401-B2 Cyclooxygenase-2 selective agents useful as imaging probes and related methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-02-12 US disclosed
US-7329401-B2 Cyclooxygenase-2 selective agents useful as imaging probes and related methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-02-12 US disclosed
US-20070286801-A1 CYCLOOXYGENASE-2 SELECTIVE AGENTS USEFUL AS IMAGING PROBES AND RELATED METHODS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2007-12-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070286801-A1 CYCLOOXYGENASE-2 SELECTIVE AGENTS USEFUL AS IMAGING PROBES AND RELATED METHODS PTGS2, PTGES2, PTGER2 ESR1 2611/4885ESR2 397/4885PTGS2 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.